Evidence map›Paper›PMID 39237127›Full record

ReviewGut2024

Where are we with gastric cancer screening in Europe in 2024?

Mārcis Leja

Abstract readReview
In one paragraph

Review in Gut, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Burden of gastric cancer attributable to Helicobacter pylori in 27 countries from seven geographic regions in 2022.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. European Cancer Prevention Organization on cancer screening: an expert panel position paper.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. FNDC1 Competitively Binds Gβ2 to Suppress the β-Catenin-Destruction Complex and Promote Gastric Cancer Malignancy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  10. Prevention of Gastric Cancer.Medicina (Kaunas, Lithuania) · 2026
    Review
  11. Article
  12. Article
  13. Post-endoscopy gastric cancer in Latin America: a multicentre cohort study from Colombia.Frontiers in gastroenterology (Lausanne, Switzerland) · 2026
    Article
  14. The importance ofFrontiers in gastroenterology (Lausanne, Switzerland) · 2026
    Review
  15. Article
  16. Short-term and long-term effects of sevoflurane inhalationWorld journal of gastrointestinal oncology · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mārcis LejaInstitute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia marcis.leja@lu.lv.ORCID 0000-0002-0319-8855

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absolute number of annual cases of gastric cancer in Europe is rising. The Council of the European Union has recommended implementation of gastric cancer screening for countries or regions with a high gastric cancer incidence and death rates. However, as of 2024 no organised gastric cancer screening programme has been launched in Europe.There are several ways to decrease gastric cancer burden, but the

Indexed as

Early Detection of CancerHelicobacter InfectionsStomach NeoplasmsEuropeHelicobacter pyloriHumansMass ScreeningGASTRIC CANCERHELICOBACTER PYLORI INFECTIONSCREENING

Identifiers

PMID39237127
PMCPMC11671906

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.